SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001062993-17-005233
Filing Date
2017-12-12
Accepted
2017-12-12 15:55:29
Documents
1
Effectiveness Date
2017-12-12
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 14442
  Complete submission text file 0001062993-17-005233.txt   15541
Mailing Address 2488 DUNWIN DRIVE MISSISSAUGA A6 L5L 1J9
Business Address 2488 DUNWIN DRIVE MISSISSAUGA A6 L5L 1J9 (416) 595-0627
Trillium Therapeutics Inc. (Filer) CIK: 0001616212 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1214
Type: D | Act: 33 | File No.: 021-300546 | Film No.: 171251770
SIC: 2834 Pharmaceutical Preparations